The Promise of Nanomedicine for Ocular Disease

• Bainbridge JW , SmithAJ, BarkerSSet al.: Effect of gene therapy on visual function in Leber‘s congenital amaurosis.N. Engl. J. Med.358, 2231–2239 (2008).
   PubMed Web of Science ®Google Scholar
• Maguire AM , SimonelliF, PierceEAet al.: Safety and efficacy of gene transfer for Leber‘s congenital amaurosis.N. Engl. J. Med.358, 2240–2248 (2008).
   PubMed Web of Science ®Google Scholar
• Cideciyan AV , AlemanTS, BoyeSLet al.: Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics.Proc. Natl Acad. Sci. USA105, 15112–15117 (2008).
   PubMed Web of Science ®Google Scholar
• Brown DM , KaiserPK, MichelsMet al.: Ranibizumab versus verteporfin for neovascular age-related macular degeneration.N. Engl. J. Med.355, 1432–1444 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ , BrownDM, HeierJSet al.: Ranibizumab for neovascular age-related macular degeneration.N. Engl. J. Med.355, 1419–1431 (2006).
   PubMed Web of Science ®Google Scholar
• Janoria KG , GundaS, BodduSH, MitraAK: Novel approaches to retinal drug delivery.Expert Opin. Drug Deliv.4, 371–388 (2007).
   PubMed Web of Science ®Google Scholar
• Sahoo SK , DilnawazF, KrishnakumarS: Nanotechnology in ocular drug delivery.Drug Discov. Today13, 144–151 (2008).
   PubMed Web of Science ®Google Scholar
• Birch DG , LiangFQ: Age-related macular degeneration: a target for nanotechnology derived medicines.Int. J. Nanomedicine2, 65–77 (2007).
   PubMed Web of Science ®Google Scholar
• Raju HB , GoldbergJL: Nanotechnology for ocular therapeutics and tissue repair.Expert Rev. Ophthalmol.3, 431–436 (2008).
   Google Scholar
• Kranz H , UbrichN, MaincentP, BodmeierR: Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.J. Pharm. Sci.89, 1558–1566 (2000).
   PubMed Web of Science ®Google Scholar
• Bourges JL , GautierSE, DelieFet al.: Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.Invest. Ophthalmol. Vis. Sci.44, 3562–3569 (2003).
   PubMed Web of Science ®Google Scholar
• Sakurai E , OzekiH, KunouN, OguraY: Effect of particle size of polymeric nanospheres on intravitreal kinetics.Ophthalmic Res.33, 31–36 (2001).
   PubMed Web of Science ®Google Scholar
• Kim H , RobinsonSB, CsakyKG: Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.Pharm. Res.26, 329–337 (2009).
   PubMed Web of Science ®Google Scholar
• Vandervoort J , LudwigA: Ocular drug delivery: nanomedicine applications.Nanomedicine2, 11–21 (2007).
   PubMed Web of Science ®Google Scholar
• Jain KK : Drug delivery systems – an overview.Methods Mol. Biol.437, 1–50 (2008).
   PubMedGoogle Scholar
• Prow T , SmithJN, GrebeRet al.: Construction, gene delivery, and expression of DNA tethered nanoparticles.Mol. Vis.12, 606–615 (2006).
   PubMed Web of Science ®Google Scholar
• Lu J , ShiM, ShoichetMS: Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors.Bioconjug. Chem.20, 87–94 (2009).
   PubMed Web of Science ®Google Scholar
• Vijayanathan V , ThomasT, ThomasTJ: DNA nanoparticles and development of DNA delivery vehicles for gene therapy.Biochemistry41, 14085–14094 (2002).
   PubMed Web of Science ®Google Scholar
• Panyam J , LabhasetwarV: Biodegradable nanoparticles for drug and gene delivery to cells and tissue.Adv. Drug Deliv. Rev.55, 329–347 (2003).
   PubMed Web of Science ®Google Scholar
• Shen J , SamulR, SilvaRLet al.: Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1.Gene Ther.13, 225–234 (2006).
   PubMed Web of Science ®Google Scholar
• Singh SR , GrossniklausHE, KangSJet al.: Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.Gene Ther.16, 645–659 (2009).
   PubMed Web of Science ®Google Scholar
• Acland GM , AguirreGD, RayJet al.: Gene therapy restores vision in a canine model of childhood blindness.Nat. Genet.28, 92–95 (2001).
   PubMed Web of Science ®Google Scholar
• Campochiaro PA , NguyenQD, ShahSMet al.: Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a Phase I clinical trial.Hum. Gene Ther.17, 167–176 (2006).
   PubMed Web of Science ®Google Scholar
• Vasir JK , LabhasetwarV: Polymeric nanoparticles for gene delivery.Expert Opin. Drug Deliv.3, 325–344 (2006).
   PubMed Web of Science ®Google Scholar
• Bejjani RA , BenEzraD, CohenHet al.: Nanoparticles for gene delivery to retinal pigment epithelial cells.Mol. Vis.11, 124–132 (2005).
   PubMed Web of Science ®Google Scholar
• Aukunuru JV , AyalasomayajulaSP, KompellaUB: Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.J. Pharm. Pharmacol.55, 1199–1206 (2003).
   PubMed Web of Science ®Google Scholar
• Marano RJ , TothI, WimmerN, BrankovM, RakoczyPE: Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity.Gene Ther.12, 1544–1550 (2005).
   PubMed Web of Science ®Google Scholar
• Farjo R , SkaggsJ, QuiambaoAB, CooperMJ, NaashMI: Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.PLoS ONE1, 1–8 (2006).
   Web of Science ®Google Scholar
• Whitehead KA , LangerR, AndersonDG: Knocking down barriers: advances in siRNA delivery.Nat. Rev. Drug Discov.8, 129–138 (2009).
   PubMed Web of Science ®Google Scholar
• Tao W , WenR, GoddardMBet al.: Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.Invest. Ophthalmol. Vis. Sci.43, 3292–3298 (2002).
   PubMed Web of Science ®Google Scholar
• Sakai T , KunoN, TakamatsuFet al.: Prolonged protective effect of basic fibroblast growth factor-impregnated nanoparticles in royal college of surgeons rats.Invest. Ophthalmol. Vis. Sci.48, 3381–3387 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang C , MooreMJ, ZhangXet al.: Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.Mol. Vis.13, 1783–1792 (2007).
   PubMed Web of Science ®Google Scholar
• Sieving PA , CarusoRC, TaoWet al.: Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants.Proc. Natl Acad. Sci. USA103, 3896–3901 (2006).
   PubMed Web of Science ®Google Scholar
• Li H , TranVV, HuYet al.: A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres.Exp. Eye Res.83, 824–833 (2006).
   PubMed Web of Science ®Google Scholar
• Diehl KA , FoleyJD, NealeyPF, MurphyCJ: Nanoscale topography modulates corneal epithelial cell migration.J. Biomed. Mater. Res. A75, 603–611 (2005).
   PubMed Web of Science ®Google Scholar
• Liu BS , YaoCH, HsuSHet al.: A novel use of genipin-fixed gelatin as extracellular matrix for peripheral nerve regeneration.J. Biomater. Appl.19, 21–34 (2004).
   PubMed Web of Science ®Google Scholar
• Ito A , HibinoE, KobayashiCet al.: Construction and delivery of tissue-engineered human retinal pigment epithelial cell sheets, using magnetite nanoparticles and magnetic force.Tissue Eng.11, 489–496 (2005).
   PubMedGoogle Scholar
• Shimizu K , ItoA, HondaH: Enhanced cell-seeding into 3D porous scaffolds by use of magnetite nanoparticles.J. Biomed. Mater. Res. B Appl. Biomater.77, 265–272 (2006).
   PubMedGoogle Scholar
• Sasaki T , IwasakiN, KohnoKet al.: Magnetic nanoparticles for improving cell invasion in tissue engineering.J. Biomed. Mater. Res. A86, 969–978 (2008).
   PubMedGoogle Scholar
• Mendes PM : Stimuli-responsive surfaces for bio-applications.Chem. Soc. Rev.37, 2512–2529 (2008).
   PubMed Web of Science ®Google Scholar
• Bawa P , PillayV, ChoonaraYE, du Toit LC: Stimuli-responsive polymers and their applications in drug delivery. Biomed. Mater.4, 22001 (2009).
   PubMed Web of Science ®Google Scholar
• Chen J , PatilS, SealS, McGinnisJF: Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides.Nat. Nanotechnol.1, 142–150 (2006).
   PubMed Web of Science ®Google Scholar
• Roy BC , BanerjeeAL, SwansonMet al.: Two-prong inhibitors for human carbonic anhydrase II.J. Am. Chem. Soc.126, 13206–13207 (2004).
   PubMed Web of Science ®Google Scholar
• Patil S , ReshetnikovS, HaldarMK, SealS, MallikS: Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fluorophores: a potential drug delivery device.J. Phys. Chem. C.111, 8437–8442 (2007).
   Web of Science ®Google Scholar
• Prow T , GrebeR, MergesCet al.: Nanoparticle tethered antioxidant response element as a biosensor for oxygen induced toxicity in retinal endothelial cells.Mol. Vis.12, 616–625 (2006).
   PubMed Web of Science ®Google Scholar
• Dagnelie G : Psychophysical evaluation for visual prosthesis.Annu. Rev. Biomed. Eng.10, 339–368 (2008).
   PubMed Web of Science ®Google Scholar
• Pan T , BrownJD, ZiaieB: An artificial nano-drainage implant (ANDI) for glaucoma treatment.Conf. Proc. IEEE Eng. Med. Biol. Soc.1, 3174–3177 (2006).
   Google Scholar
• Kapoor Y , ThomasJC, TanG, JohnVT, ChauhanA: Surfactant-laden soft contact lenses for extended delivery of ophthalmic drugs.Biomaterials30, 867–878 (2009).
   PubMed Web of Science ®Google Scholar

Website

• Parviz BA, Shen TT, Ho H: Functional contact lens with integrated inorganic microstructures. Invest. Ophthalmol. Vis. Sci. 49 (2008) (ARVO E-abstract 4783). www.arvo.org
   Google Scholar